Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Pre-transplant immune profile defined by principal component analysis predicts acute rejection after kidney transplantation

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Centre d'Investigation Clinique de Besançon (Inserm CIC 1431); Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang Bourgogne-Franche-Comté (EFS BFC)-Université de Franche-Comté (UFC); Université Bourgogne Franche-Comté COMUE (UBFC)-Université Bourgogne Franche-Comté COMUE (UBFC); Interactions hôte-greffon-tumeur, ingénierie cellulaire et génique - UFC (UMR INSERM 1098) (RIGHT); Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang Bourgogne-Franche-Comté (EFS BFC)-Université de Franche-Comté (UFC); Service de Néphrologie CHRU Besançon; Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon); Centre de Recherche en Transplantation et Immunologie - Center for Research in Transplantation and Translational Immunology (U1064 Inserm - CR2TI); Institut National de la Santé et de la Recherche Médicale (INSERM)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE); Nantes Université - pôle Santé; Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé; Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ); Team 4 : Deciphering organ immune regulation in inflammation and transplantation (DORI-t) (Team 4 - U1064 Inserm - CR2TI); Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE); Institut de Transplantation et de Recherche en Transplantation CHU Nantes (ITERT); Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes); Autoimmunité, Transplantation, et Inflammation (UMR 1098) (Equipe ATI); Université Bourgogne Franche-Comté COMUE (UBFC)-Université Bourgogne Franche-Comté COMUE (UBFC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang Bourgogne-Franche-Comté (EFS BFC)-Université de Franche-Comté (UFC); This study was supported by grants from the national “Programme Hospitalier de Recherche Clinique” (PHRC 2005), The Fondation de France (2007), The Fondation transplantation (2008), The “Direction générale de l’Offre de soins – Institut national de la santé et de la recherche médicale” grant (DHOS INSERM 2008) and the interregional “Programme Hospitalier de Recherche Clinique” (PHRC-Interreg 2011).
    • بيانات النشر:
      HAL CCSD
      Frontiers
    • الموضوع:
      2023
    • Collection:
      Université de Franche-Comté (UFC): HAL
    • نبذة مختصرة :
      International audience ; Background : Acute rejection persists as a frequent complication after kidney transplantation. Defining an at-risk immune profile would allow better preventive approaches. Methods : We performed unsupervised hierarchical clustering analysis on pre-transplant immunological phenotype in 1113 renal transplant recipients from the ORLY-EST cohort. Results : We identified three immune profiles correlated with clinical phenotypes. A memory immune cluster was defined by memory CD4 + T cell expansion and decreased naïve CD4 + T cell. An activated immune cluster was characterized by an increase in CD8 + T cells and a decreased CD4/CD8 ratio. A naïve immune cluster was mainly defined by increased naïve CD4 + T cells. Patients from the memory immune profile tend to be older and to have diabetes whereas those from the activated immune profile were younger and more likely to have pre-transplant exposure to CMV. Patients from the activated immune profile were more prone to experience acute rejection than those from other clusters [(HR=1.69, 95%IC[1.05-2.70], p=0.030) and (HR=1.85; 95%IC[1.16-3.00], p=0.011). In the activated immune profile, those without previous exposure to CMV (24%) were at very high risk of acute rejection (27 vs 16%, HR=1.85; 95%IC[1.04-3.33], p=0.039).Conclusion : Immune profile determination based on principal component analysis defines clinically different sub-groups and discriminate a population at high-risk of acute rejection.
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/37497224; inserm-04214674; https://inserm.hal.science/inserm-04214674; https://inserm.hal.science/inserm-04214674/document; https://inserm.hal.science/inserm-04214674/file/fimmu-14-1192440.pdf; PUBMED: 37497224; PUBMEDCENTRAL: PMC10367005
    • الرقم المعرف:
      10.3389/fimmu.2023.1192440
    • الدخول الالكتروني :
      https://inserm.hal.science/inserm-04214674
      https://inserm.hal.science/inserm-04214674/document
      https://inserm.hal.science/inserm-04214674/file/fimmu-14-1192440.pdf
      https://doi.org/10.3389/fimmu.2023.1192440
    • Rights:
      info:eu-repo/semantics/OpenAccess
    • الرقم المعرف:
      edsbas.1EA7AD3C